MiRus® Email Format
Biotechnology ResearchGeorgia, United States51-200 Employees
MiRus™ is a privately held medical device company founded in 2016 and based in Marietta, Georgia. It focuses on designing solutions for spinal and orthopedic degeneration and deformities, as well as structural heart disease, addressing care across preoperative, intraoperative, and postoperative stages. The company emphasizes its use of a proprietary alloy and innovative implant designs, complemented by procedure solutions and remote physiological monitoring to support outcomes across the continuum of care. Customers include surgeons and hospitals within spine and orthopedics, and providers involved in structural heart care, seeking innovative devices to improve surgical and recovery outcomes. Within the spine, orthopedics, and structural heart disease markets, MiRus aims to support clinicians with implant systems and related workflow solutions that enhance outcomes over the patient care continuum. Recent regulatory recognition came in 2024 when the company was awarded FDA Breakthrough Device Designation for the EUROPA Posterior Cervical System, reflecting progress in its rhenium-alloy-based implants.